Carly Robinson

Associate
Full contact info

Experience

Scorpion Therapeutics Enters Collaboration Agreement with AstraZeneca

January 14, 2022

Cooley advised Scorpion Therapeutics in its collaboration agreement with AstraZeneca to discover, develop and commercialize precision medicines against previously hard-to-target cancer proteins, with the potential to transform oncology treatment.

Under the terms of the collaboration agreement, Scorpion will receive an upfront cash payment of $75 million and is eligible to receive additional success-based payments in the form of option fees and milestone payments, as well as tiered royalties on net sales ranging from mid-single digit to low-double digits. In the event Scorpion opts into co-developing and co-promoting a nominated program, Scorpion will participate in the operating costs and be entitled to a proportionate share of the economics in the US, subject to certain adjustments.

 

Related contacts

Christophe Beauduin
Special Counsel, New York
Carly Robinson
Associate, Reston

Related Practices & Industries

Immatics Enters Global Exclusive License Agreement With Bristol Myers Squibb

December 22, 2021

Cooley advised Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, on its license, development and commercialization agreement with Bristol Myers Squibb for its TCR bispecific candidate, IMA401. Lawyers Ken Krisko, Carly Robinson, Brian Stalter and Stephanie Palmer led the Cooley team advising Immatics.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Carly Robinson
Associate, Reston
J. Brian Stalter
Special Counsel, New York
Stephanie Parker Palmer
Special Counsel, Reston
Nicollette R. Kirby
Associate, Washington, DC
Alexander Israel
Partner in Charge – Brussels, Brussels
Jan Lang
Associate, Brussels
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
Rachel Thorn
Partner, New York
Patrick Van Eecke
Partner, Brussels
Bartholomäus Regenhardt
Associate, Brussels
Stella Sarma
Special Counsel, Brussels
Christine Graham
Special Counsel, London
Douglas Lyles
Senior Research Services & Access Analyst

Related Practices & Industries

Prothena Agrees to Sell ATTR Amyloidosis Program to Novo Nordisk

July 27, 2021

Cooley advised Prothena, a late-stage clinical company with a robust pipeline of novel investigational therapeutics, on its agreement to sell its clinical-stage antibody PRX004 and broader amyloid transthyretin (ATTR) amyloidosis program to Novo Nordisk for $1.2 billion. Partners Marya Postner and Barbara Borden led the Cooley team advising Prothena.

Read more

Related contacts

Marya Postner
Partner, Palo Alto
Barbara Borden
Partner, San Diego
Rowook Park
Partner, San Diego
Nicholaus E. Johnson
Associate, San Diego
Carly Robinson
Associate, Reston

Related Practices & Industries

RayzeBio Signs Approximately $4.1 Billion Acquisition Agreement With Bristol Myers Squibb

December 26, 2023

Cooley advised RayzeBio, a clinical-stage radiopharmaceutical therapeutics (RPT) company with an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs, on its definitive agreement to be acquired by Bristol Myers Squibb.

Read more

Related contacts

Jamie Leigh
Partner, San Francisco
Ben Beerle
Partner, San Francisco
Rowook Park
Partner, San Diego
Sangitha Palaniappa
Associate, Palo Alto
Caitlin Breitenbruck
Associate, Seattle
Tyler McClure
Associate, San Francisco
Carlos Ramirez
Partner, San Diego
Terren O'Connor
Associate, San Diego
Christine S. Kim
Associate, San Diego
Michelle Hunt
Associate
Marya Postner
Partner, Palo Alto
Carly Robinson
Associate, Reston
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Christopher Kimball
Partner, Washington, DC
David Fletcher
Partner, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC
Sarah Oliai
Associate, Washington, DC
Alessandra Murata
Partner, Palo Alto
Tony P. Guan
Associate, Los Angeles Santa Monica
Ross Eberly
Partner, Los Angeles Santa Monica
Eileen Leman
Associate, Los Angeles Downtown
Todd Gluth
Partner, San Diego
Jeffrey J. Tolin
Partner, New York
Howard Morse
Partner, Washington, DC
Megan Browdie
Partner, Washington, DC
Nicollette R. Kirby
Associate, Washington, DC

Related Practices & Industries

Lexeo Therapeutics Announces $100 Million IPO

November 3, 2023

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Read more

Related contacts

Eric Blanchard
Partner, Boston
Peter Byrne
Partner, New York
Div Gupta
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Xander Lee
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Aaron Pomeroy
Partner, Colorado
Phil Mitchell
Partner, New York
Mark Ballantyne
Partner, Reston
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Stephanie Parker Palmer
Special Counsel, Reston
Joseph Lockinger
Special Counsel, Washington, DC
Christophe Beauduin
Special Counsel, New York
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Dayne Brown
Associate, New York
Ibe Alozie
Associate, Washington, DC
Christopher Nickas
Associate, New York
DeVon Barnett
Associate, Washington, DC
Carly Robinson
Associate, Reston
Calvin Lee
Associate, New York
Jayne M. Munger
Associate, New York
Megan Drill
Associate, San Diego
Erika Freeman
Associate, New York
Mor Agam
Associate, New York
Wyatt Kernell
Associate, New York
Wyatt Kernell
Associate, New York
Alexander Fullman
Associate, New York
Jason Minio
Paralegal Specialist, Boston
Andrew Henderson
Patent Agent, Seattle

Related Practices & Industries

View more

Admissions & credentials

Virginia

District of Columbia

Memberships & affiliations

Virginia Bar Association